卫宁健康收盘下跌2.15%，滚动市盈率302.30倍，总市值231.45亿元

Core Viewpoint - The company, Weining Health, is experiencing a significant decline in its financial performance, with a high price-to-earnings (PE) ratio compared to industry averages, indicating potential overvaluation in the context of its recent earnings report [1][2]. Company Summary - Weining Health's stock closed at 10.46 yuan, down 2.15%, with a rolling PE ratio of 302.30 times, and a total market capitalization of 23.145 billion yuan [1]. - The company operates in the software development sector, which has an average PE ratio of 125.57 times and a median of 85.99 times, placing Weining Health at the 175th position in the industry ranking [1]. - As of the first quarter of 2025, 13 institutions hold shares in Weining Health, all being funds, with a total holding of 30.8435 million shares valued at 327 million yuan [1]. Financial Performance - In the first quarter of 2025, Weining Health reported a revenue of 345 million yuan, representing a year-on-year decrease of 30.24%, and a net profit of 5.2894 million yuan, down 68.18% year-on-year, with a gross margin of 34.46% [1].